Sara Pepe

616 total citations
35 papers, 366 citations indexed

About

Sara Pepe is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Sara Pepe has authored 35 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 15 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Sara Pepe's work include Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Acute Myeloid Leukemia Research (6 papers). Sara Pepe is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Acute Myeloid Leukemia Research (6 papers). Sara Pepe collaborates with scholars based in Italy, United States and Japan. Sara Pepe's co-authors include Emilia Scalzulli, Massimo Breccia, Gioia Colafigli, Simone Polvani, Andrea Galli, Stefano Milani, Márta Korbonits, Donato Iacovazzo, Barbara Stecca and Robin Foà and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sara Pepe

31 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Pepe Italy	9	162	104	97	77	74	35	366
Naïs Prade France	7	197 1.2×	63 0.6×	95 1.0×	176 2.3×	90 1.2×	8	395
Sarah Moore Australia	12	175 1.1×	173 1.7×	136 1.4×	265 3.4×	46 0.6×	32	563
Iris Appelmann Germany	11	236 1.5×	78 0.8×	70 0.7×	108 1.4×	55 0.7×	22	438
Deog Yeon Jo South Korea	11	162 1.0×	38 0.4×	232 2.4×	142 1.8×	111 1.5×	31	447
Michiaki Koike Japan	12	187 1.2×	100 1.0×	129 1.3×	178 2.3×	100 1.4×	48	509
Norihiro Awaya Japan	12	203 1.3×	122 1.2×	120 1.2×	204 2.6×	90 1.2×	26	474
Abd Aziz Ibrahim Japan	8	172 1.1×	71 0.7×	61 0.6×	162 2.1×	87 1.2×	12	397
Takuma Ishizaki Japan	11	193 1.2×	54 0.5×	61 0.6×	113 1.5×	88 1.2×	45	414
Chuen‐Miin Leu Taiwan	8	158 1.0×	40 0.4×	69 0.7×	22 0.3×	169 2.3×	12	374
Luk Cox Belgium	9	195 1.2×	97 0.9×	99 1.0×	115 1.5×	59 0.8×	12	432

Countries citing papers authored by Sara Pepe

Since Specialization

Citations

This map shows the geographic impact of Sara Pepe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Pepe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Pepe more than expected).

Fields of papers citing papers by Sara Pepe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Pepe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Pepe. The network helps show where Sara Pepe may publish in the future.

Co-authorship network of co-authors of Sara Pepe

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Pepe. A scholar is included among the top collaborators of Sara Pepe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Pepe. Sara Pepe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pepe, Sara, et al.. (2025). Common brain areas in spatial navigation and visuo-spatial planning: A meta-analysis. Neuroscience & Biobehavioral Reviews. 176. 106295–106295. 1 indexed citations

Andreotti, Mauro, Francesca Romana Mauro, S Zamboni, et al.. (2025). A New Antibody–Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia. Biomolecules. 15(1). 117–117. 1 indexed citations

Wakabayashi, Taiga, Sara Pepe, Muhammad Naeem, & Go Wakabayashi. (2025). Robotic bona fide right hepatectomy with ICG-guided detachment technique. Surgical Oncology. 64. 102338–102338.

Pepe, Sara, Emilia Scalzulli, Ida Carmosino, et al.. (2024). Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation. European Journal Of Haematology. 112(6). 938–943. 3 indexed citations

Pepe, Sara, Giuseppe Giannini, Serena Sestini, et al.. (2023). Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth. Pharmacological Research. 195. 106858–106858. 16 indexed citations

Goglia, Marta, Sara Pepe, Andrea Minervini, et al.. (2023). Complication of Gastric Cancer Surgery: A Single Centre Experience. In Vivo. 37(5). 2166–2172. 4 indexed citations

Pepe, Sara, Ursula La Rocca, Maria Stefania De Propris, et al.. (2023). Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS. Frontiers in Oncology. 13. 1171031–1171031. 2 indexed citations

Manetti, Fabrizio, Sara Pepe, Elena Cini, et al.. (2022). Quinolines and Oxazino-quinoline Derivatives as Small Molecule GLI1 Inhibitors Identified by Virtual Screening. ACS Medicinal Chemistry Letters. 13(8). 1329–1336. 7 indexed citations

Pepe, Sara, Elena Rossi, Malgorzata Monika Trawinska, et al.. (2022). Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group. Annals of Hematology. 101(6). 1275–1282. 3 indexed citations

10.

Scalzulli, Emilia, Giovanni Caocci, Fabio Efficace, et al.. (2021). Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients. Annals of Hematology. 100(5). 1213–1219. 3 indexed citations

11.

Pepe, Sara, Emilia Scalzulli, Gioia Colafigli, et al.. (2021). Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience. Leukemia & lymphoma. 62(9). 2261–2266.

12.

Scalzulli, Emilia, Gioia Colafigli, Roberto Latagliata, et al.. (2020). Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients. Annals of Hematology. 99(12). 2773–2777. 3 indexed citations

13.

Montagnani, Valentina, et al.. (2020). E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis. Journal of Biological Chemistry. 295(47). 16058–16071. 11 indexed citations

14.

Colafigli, Gioia, Emilia Scalzulli, Sara Pepe, et al.. (2020). Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?. Critical Reviews in Oncology/Hematology. 157. 103163–103163. 13 indexed citations

15.

Mauro, Francesca Romana, Diana Giannarelli, Clementina Maria Galluzzo, et al.. (2020). Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL). Leukemia. 35(3). 737–746. 51 indexed citations

16.

Pietrobono, Silvia, Fabrizio Manetti, Luciana L. Almada, et al.. (2020). ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL. Nature Communications. 11(1). 5865–5865. 66 indexed citations

17.

Scalzulli, Emilia, Gioia Colafigli, Sara Pepe, et al.. (2020). Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up. Leukemia & lymphoma. 62(4). 1026–1027. 3 indexed citations

18.

Colafigli, Gioia, Emilia Scalzulli, Sara Pepe, et al.. (2020). The advantages and risks of ruxolitinib for the treatment of polycythemia vera. Expert Review of Hematology. 13(10). 1067–1072. 7 indexed citations

19.

Mauro, Francesca Romana, et al.. (2018). Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia. Expert Review of Hematology. 11(8). 601–611. 8 indexed citations

20.

Cascone, Tina, Floriana Morgillo, Gianluca Laus, Sara Pepe, & Fortunato Ciardiello. (2006). 397 POSTER Potentiation of the antitumor activity of bortezomib, a proteasome inhibitor, by the combination with EGFR inhibitors in human cancer cell lines. European Journal of Cancer Supplements. 4(12). 122–122. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact